Skip to Content

Triptorelin Pregnancy and Breastfeeding Warnings

Triptorelin is also known as: Trelstar, Trelstar Depot, Trelstar LA, Triptodur

Triptorelin Pregnancy Warnings

Animal studies during organogenesis showed embryo-fetal toxicities of pre-implantation loss, increased resorption, and reduced number of viable fetuses. There are no adequate or well-controlled studies in pregnant women. Expected treatment related hormonal changes increase the risk for pregnancy loss. AU TGA pregnancy category D: Drugs which have caused, are suspected to have caused or may be expected to cause, an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects. Accompanying texts should be consulted for further details. US FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

Use is contraindicated. (US) Some formulations are not indicated for use in female patients; formulations approved for use in females are contraindicated during pregnancy. (UK) This drug is not indicated for use in female patients. (AU) AU TGA pregnancy category: D US FDA pregnancy category: X Comments: -Rule out pregnancy prior to treatment. -Women of childbearing potential should use effective non-hormonal contraception during therapy until menses resume. -If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.

See references

Triptorelin Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: There is a potential for serious adverse reactions in nursing infants.

See references

References for pregnancy information

  1. "Product Information. Trelstar (triptorelin)" Pharmacia and Upjohn, Kalamazoo, MI.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  4. Elefant E, Biour B, Blumberg-Tick J, Roux C, Thomas F "Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline." Fertil Steril 63 (1995): 1111-3
  5. Chardonnens D, Sylvan K, Walker D, Bischof P, Sakkas D, Campana A "Triptorelin acetate administration in early pregnancy: case reports and review of the literature." Eur J Obstet Gyn Reprod Biol 80 (1998): 143-9

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Trelstar (triptorelin)" Pharmacia and Upjohn, Kalamazoo, MI.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.